Drug recall · December 17, 2014
Famotidine Injection 20 mg recall
Why: Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-5197-41.
- Lots / codes
Lot #: NC082768, Exp 12/23/2014
- Quantity
- 19,152 Containers
- Company
- Baxter Healthcare Corp., Deerfield, IL
- Distribution
- Nationwide
- Initiated
- April 24, 2014 · Voluntary: Firm initiated
- Classified
- December 10, 2014
- Reported
- December 17, 2014
- Ended
- June 16, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Famotidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.